Skip to content
Screener

Price / book at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.6×+0.6×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
2.1×+0.2×
SIGA Technologies logo
SIGA TechnologiesSIGA
1.6×-0.6×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
167.4×
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
194×+178×
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
4.9×+2.1×

Other financials

Income statement

See full
Revenue$234.3M+66.3%
Gross profit$137.2M+85.4%
Operating income-$125.1M-7,919%
Net income-$180.2M-1,402%
EPS (diluted)-$3.49-1,486%

Balance sheet

See full
Cash & equivalents$140.9M-48.0%
Total debt$588.2M-13.0%
Total equity$341.4M-36.3%
Total assets$1.1B-21.2%

Cash flow

See full
Operating cash flow$56.1M-47.3%
CapEx$2.1M-27.6%
Free cash flow$54.0M-47.8%

Valuation

See full
Market cap$248.16M-47.4%
Enterprise value$695.46M-19.5%
P/S0.3×-0.2×

Profitability

See full
Gross margin55.9%+2.4pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin11.9%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.7×+0.5×
Current ratio5.4×-0.2×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

Based on the most recent quarter.

The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001367644-26-000082

FAQ

What is Emergent Biosolutions's price / book?
Emergent Biosolutions (EBS) reported price / book of 1.3× in Q2 2026.
How has Emergent Biosolutions's price / book changed year-over-year?
Emergent Biosolutions's price / book increased by 84.8% year-over-year, from 0.7× to 1.3×.
What is the long-term trend for Emergent Biosolutions's price / book?
Over 5 years (2020 to 2025), Emergent Biosolutions's price / book has grown at a -17.9% compound annual growth rate (CAGR), from 3.3× to 1.2×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Emergent Biosolutions's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude